Goldstein Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Goldstein Advisors's LLY Position: Q2 2026 in Review
Goldstein Advisors reduced its Eli Lilly (LLY) stake by 0.19% in Q2 2026, selling an estimated $1.02K and leaving 525 shares worth $630K. The position accounts for 0.06% of the portfolio, ranked #112.
Goldstein Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Goldstein Advisors held 525 shares of Eli Lilly worth $630K as of Q2 2026.
- Goldstein Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 0.06% of Goldstein Advisors's portfolio in Q2 2026, its #112 holding.
- Goldstein Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
- 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.